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F-SPONDIN (SPONDIN-1) NULL MICE EXHIBIT INCREASED BONE
FORMATION, DECREASED OSTEOCLAST FUNCTION AND ACCELERATED
OSTEOARTHRITIS
M. Attur 1, G. Palmer 1, J. Liu 1, Y. Qing 1, D. Rifkin 2, D. Bryce 3, F. Beier 4,
S.B. Abramson 1. 1NYUHosp. for Joint Diseases, New York, NY, USA; 2NYU
Dept. of Cell Biology, New York, NY, USA; 3 Schulich Sch. of medicine and
Dentistry, Univ. of Western Ontario, London, ON, Canada; 4 Schulich Sch. of
Med. and Dentistry, Univ. of Western Ontario, London, ON, Canada
Purpose: We have previously reported that F-spondin (spondin-1),
a neuroregulatory protein, is upregulated by chondrocytes in osteoar-
thritis. These studies showed that spondin-1, a member of the TSR
(thrombospondin) type I class super family, activated latent TGF-b1, which
appeared to account for selected in vitro effects, including induction of the
hypertrophic chondrocyte phenotype. In this study we generated Spon1
knockout mice to investigate the effect of F-spondin in vivo in i) skeletal
development and ii) OA progression following surgical destabilization of
the medial meniscus (DMM).
Methods: Knockout mice were generated in collaboration with the Texas
Institute of Genomic Medicine by targeted deletion of exon 1 in C57BL/6
mice. Exon deletion was conﬁrmed by Southern blot analysis and PCR
using probes speciﬁc for wild type (WT) and mutant loci. Total TGFb-1 was
detected using R &D ELISA kit. MicroCt was performed on the Scanco mCT
35 system on proximal tibia and femurs bone evaluation. Values represent
the average of 10 WT and 11 KO mice. To assess the role of Spon1 on OA
progression following destabilization of the medial meniscus was per-
formed on 3 month old WT and Spon1-/- mice.
Results: Spon1-/- null mice were viable and initial macroscopic observa-
tions revealed no overt differences in size and body weight compared
with WT (mice up to 6 months). Since we previously reported spondin-1
to regulate TGF-b activity, we measured TGF-b1 serum levels in adult
mutant mice. Relative to WT, Spon1 deletion reduced serum levels of
total TGF-b1 (82  20 ng/ml vs. 30  25.0 ng/ml; p<0.002). Similarly,
cultured chondrocytes isolated from the rib cages of 5 day old Spon1-/-
mice also produced signiﬁcantly less TGF-b1 (30%) compared to WT
controls (p<0.01). To determine whether Spon1 deletion affected bone
phenotype, we performed microCT of tibia and femurs in mutant and WT
mice aged 1-6 months Relative to WT mice, Spon1-/- exhibited increased
bone formation at 6 months (Figure 1), evidenced by, a) increased
trabecular and cortical bone volume fraction (Bone volume/Total volume:
0.26  0.03 versus 0.16  0.05, p<0.0002; Fig 1), b) decreased trabecular
spacing (0.14  0.02 versus 0.19 0.03, p<0.0003); and c) increased
trabecular number (7.7  1.2, versus 5.5  0.9, p<0.0005). Interestingly,
no signiﬁcant changes were observed at 1 or 3 months, suggesting that
Spon1 effects are age-dependent. Histologically, tibia from Spon1-/- mice
displayed increased bone ingrowth in the bone marrow cavity, particu-
larly within the spongy bone of the ephysiseal regions. This was
accompanied by decreased TRAP staining compared to WT mice, sug-
gesting decreased numbers of osteoclasts. Supporting this observation,
osteoclast differentiation, performed by RANKL, M-CSF induction of non-
adherent bone-marrow cells, revealed impaired differentiation in Spon1-/-
mice compared to WT.
Preliminary analyses suggest that Spon1 deletion also accelerated carti-
lage degradation in the DMM model of osteoarthritis. The increased
severity of osteoarthritis-like cartilage destruction 7 weeks post surgery
was by accompanied by increased thickening of subchondral bone
(Figure 2).
Conclusions: Our studies indicate that spondin-1 (F-spondin), a latent
TGF-b1 activating ECM protein, over-expressed in OA bone and
cartilage, regulates bone metabolism in aging mice. Spon1-/- mice
exhibit increased trabecular and cortical bone formation, decreased
osteoclast function and increased susceptibility to surgical induced
OA. Together these data suggest that a primary function of spondin-1
in skeletal tissue is the regulation of bone mass via latent TGF-b1
activation. Further studies are in progress regarding the potential of
spondin-1 as a drugable target in future therapy of osteoporosis or
osteoarthritis.103
GENE ARRAY PROFILING OF ARTICULAR CHONDROCYTES IN MICE WITH
DIFFERENT SUSCEPTIBILITY TO NATURAL DISEASE REVEALS SPECIFIC
GENE SIGNATURES LINKED TO HEALTHY AGEING AND SPONTANEOUS
OA.
B. Poulet 1, U. Veronica 2, T.C. Stone 1, M. Pead 1, V. Gburcik 1, F. Beier 2,
J.A. Timmons 1, A.A. Pitsillides 1. 1 The Royal Vet. Coll., London, United
Kingdom; 2Univ. of Western Ontario, London, ON, Canada
Purpose: The mechanisms initiating and driving spontaneous osteoar-
thritis (OA) progression remain largely unknown. The Str/ort mouse strain
has high natural susceptibility to OAwith ageing, whereas CBA mice show
little, if any, spontaneous OA development. In this study, we used this
inter-strain variability to spontaneous OA in mice at various ages to
determine articular cartilage (AC) gene expression patterns and biological
pathways that contribute to normal, healthy and osteoarthritic AC ageing
and that play a role in susceptibility to OA.
Methods: AC from Str/ort and CBAmice at 8 (before overt OA in Str/ort), 18
(early OA) and 40wks of age (late OA) were isolated from tibial and femoral
knee joint condyles and RNA extracted (n¼4 per group) for gene expres-
sion microarray analysis. Ingenuity pathway analysis was performed for
each comparison: 8 vs. 40wks CBA, 8 vs. 40wks Str/ort, 8wks CBA vs. Str/
ort, 8 vs. 18wks Str/ort. RT-qPCR was performed on selected genes.
Results: Proﬁling in 8 and 40wk-old CBA mice was used to pinpoint gene
signatures linked to healthy AC ageing. This comparison revealed 190
differentially-regulated genes (50 up,140 down), which did not include any
genes previously linked to OA, except CILP and HDAC5. Pathway analysis
revealed that skeletal muscle-speciﬁc genes were signiﬁcantly down-
regulated in the AC of CBAmice with ageing from 8-40wks. Changes in this
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mice and these differences conﬁrmed by RT-qPCR for Myf6 and Myh1.
Comparison of Str/ort mice at these same ages, during which OA develops,
showed 279 differentially regulated genes (47 up, 232 down) and these
were mainly centred on the signalling via the NFkB complex.
To determine the gene expression patterns related to OA susceptibility,
8wk-old CBA and Str/ort mice AC were compared. This showed up-regula-
tionof 139genes (nonedown-regulated), includingHtra1 andTIMP1,which
was again centred primarily on NFkB pathway signalling. Immunolabelling
ofAC sections showed that theNfkB-p65proteinwasmorehighlyexpressed
in chondrocytes of 8wk-old Str/ort than in aged-matched CBA mice.
To deﬁne gene proﬁles speciﬁc to early OA, AC from 8 and 18wks old Str/ort
mice was compared. This showed 113 down-regulated and only 2 up-
regulated genes and pathway analysis showed that these were again
centred on the NFkB pathway. Interestingly, no genes were differentially
regulated between 18 and 40wks in Str/ort mice, suggesting that similar
processes are taking place in both early and late-stage OA.
Conclusions: We ﬁnd that AC chondrocytes express skeletal muscle-
related genes in young mice that are lost during normal healthy ageing but
retained during OA. In addition, our data support the involvement of NFkB
pathway signalling in susceptibility of AC to spontaneous OA and to OA
progression. This study highlights these molecular processes as possible
markers of OA and targets for slowing OA development.
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GENERATION OF AN INDUCIBLE CARTILAGE SPECIFIC DELETER USING
HUMAN AGGRECAN ENHANCER/PROMOTER THAT IS TRACKABLE IN
VIVO USING LUCIFERASE
G. Bou-Gharios, A. Layyous, K. Liu, H. Nakamura, L. Lo Cascio,
J. Saklatvala. Kennedy Inst. of Rheumatology, London, United Kingdom
Purpose: To generate a chondrocyte-speciﬁc deleter which can be
visualised in vivo. We needed an improvement on the collagen type II
which is signiﬁcantly reduced in adult articular cartilage and expresses in
kidney during development
Methods:We have utilized a transgenic approach where we have used the
human aggrecan enhancer/promoter to drive inducible Cre recombinase
(Cre-ERT2) followed by an IRES luciferase forming a bicistronic mRNA in
transgenic mice.
Results:The expression and efﬁciencyof the inducible cre recombinasewas
tested by examining X-gal staining of tissues from embryos as well as adult
in double transgenic with Rosa 26R mice. Cre recombinase was induced by
tamoxifen, at different time points during development and postnatally. X-
gal staining was observed in growth plate and articular cartilage as well as
theﬁbrocartilage ofmeniscus, trachea, and intervertebral discs reproducing
the pattern of endogenous aggrecan gene expression.
In addition to this mouse being an efﬁcient deleter, the presence of lucif-
erase allows the visualization of aggrecan expression in vivo. This has been
tested before or after the induction of osteoarthritis through destabilisa-
tion of the medial meniscus ligament up to eight weeks post surgery.
Conclusions: The aggrecan-CreERT2 will help us determine genes
involvement in the integrity of the cartilage and visualize this complex in
osteoarthritis
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DEFICIENCY OF NFAT1 TRANSCRIPTION FACTOR CAUSES
OSTEOARTHRITIS WITH ALTERATIONS IN ARTICULAR CARTILAGE AND
SUBCHONDRAL BONE IN ADULT MICE
J. Wang, B. Gardner, Q. Lu, M. Shaath, K. Brandt, H. Anderson. Univ. of
Kansas Med. Ctr., Kansas City, KS, USA
Purpose: One of the barriers to progress in OA research is the difﬁculty in
obtaining human joint tissue samples at an early stage of OA that permits
studies of the mechanisms for initiation of OA. Many animal models have
been developed to explore the mechanisms of human OA. However,
surgically- or chemically-induced OA models often display rapidly
progressive joint lesions and may not be suitable for studying the etio-
pathogenesis of more slowly progressive non-traumatic OA in humans.
Murine models of OA developed by spontaneous or genetically-inducedmutations of genes for cartilage matrix proteins or growth factors are often
accompanied by developmental defects in the skeletal system (e.g., mice
harboringmutations in aggrecan or type-II collagen). Notably, these mouse
models usually do not show subchondral bone changes, an important
pathogenetic feature of human OA. Therefore, there is a crucial need for
animal models that mimic the pathologic characteristics of idiopathic
human OA to study the mechanisms for initiation and progression of OA.
Methods: We examined whether deletion of Nfat1, a transcription factor
previously reported as a regulator of the expression of cytokine genes
during the immune response, would alter the expression of speciﬁc
proinﬂammatory cytokines and display osteoarthritic changes in articular
tissues of mice.
Results: The results revealed that deletion of Nfat1 transcription factor in
mice caused classic OA changes, including alterations in articular cartilage
and subchondral bone that mimic those in human OA. Nfat1-deﬁcient mice
exhibited normal skeletal development but displayed loss of type-II collagen
and aggrecan in young adult articular cartilage of load-bearing joints. These
early changes were followed by articular chondrocyte proliferation/clus-
tering, thickening of subchondral bone, slow progression of articular surface
destruction, and formation of chondro-osteophytes. Overexpression of
speciﬁc matrix-degrading proteinases and proinﬂammatory cytokines was
observed in Nfat1-deﬁcient articular cartilage and synovium. We identiﬁed
Nfat1 binding sites in the promoters of the genes for mouse and human
interleukin-1b, tumor necrosis factor-a, matrix metalloproteinase-13
(MMP13), and a disintegrin and metalloproteinase with thrombospondin
motifs-4,5 (ADAMTS-4,5), suggesting that Nfat1 may be an upstream regu-
lator of these catabolic molecules that degrade articular cartilage.
Conclusions: These novel ﬁndings suggest that Nfat1-deﬁcient mouse
may serve as a more suitable surrogate of human OA than murine OA
models that do not exhibit subchondral bone changes. Because Nfat1
regulates multiple matrix-degrading proteinases and proinﬂammatory
cytokines in articular tissues, anti-OA agents that target Nfat1 could be
more effective than drug candidates that target a single catabolic molecule.
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EARLY INTERVENTION TO PREVENT CARTILAGE DEGENERATION BY
ADMINISTRATION OF ANTI-VEGF ANTIBODY IN RABBIT MODEL
T. Nagai, M. Sato, T. Kutsuna, T. Ukai, M. Kobayashi, J. Mochida. Tokai Univ.,
Kanagawa Isehara, Japan
Purpose: We have previously constructed and transplanted scaffold-free
tissue-engineered cartilage into an osteochondral defect (Tissue Eng Part A
2008;14:1183-1193), and conﬁrmed that reparative cells derived from
